These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24971499)

  • 1. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.
    Lee JJ; Lin MY; Chang JS; Hung CC; Chang JM; Chen HC; Yu ML; Hwang SJ
    PLoS One; 2014; 9(6):e100790. PubMed ID: 24971499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
    Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
    Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection.
    Chen YC; Li CY; Tsai SJ; Chen YC
    World J Gastroenterol; 2018 Feb; 24(8):917-928. PubMed ID: 29491685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France.
    Isnard Bagnis C; Couchoud C; Bowens M; Sarraj A; Deray G; Tourret J; Cacoub P; Tezenas du Montcel S
    Liver Int; 2017 Jun; 37(6):820-826. PubMed ID: 28107607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
    Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
    AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure.
    Hwang JC; Jiang MY; Lu YH; Weng SF
    Medicine (Baltimore); 2016 Jan; 95(3):e2431. PubMed ID: 26817874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals.
    Chen YC; Li CY; Tsai SJ; Chen YC
    World J Clin Cases; 2019 Jun; 7(11):1270-1281. PubMed ID: 31236391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?
    Vladutiu DS; Cosa A; Neamtu A; State D; Braila M; Gherman M; Patiu IM; Dulau-Florea I
    J Viral Hepat; 2000 Jul; 7(4):313-9. PubMed ID: 10886543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C virus infection in Crohn's disease.
    Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
    Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria.
    Oje OJ; Sule WF; Famurewa D
    Viral Immunol; 2012 Dec; 25(6):448-55. PubMed ID: 23171358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
    BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.
    Wei YJ; Hsu PY; Lee JJ; Niu SW; Huang JC; Hsu CT; Jang TY; Yeh ML; Huang CI; Liang PC; Lin YH; Hsieh MY; Hsieh MH; Chen SC; Dai CY; Lin ZY; Chen SC; Huang JF; Chang JM; Hwang SJ; Chuang WL; Huang CF; Chiu YW; Yu ML
    J Viral Hepat; 2021 May; 28(5):719-727. PubMed ID: 33533547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.